Insulin and atherosclerosis: villain, accomplice, or innocent bystander?
作者信息
Savage P J, Saad M F
出版信息
Br Heart J. 1993 Jun;69(6):473-5. doi: 10.1136/hrt.69.6.473.
Abstract
摘要
相似文献
1
Insulin and atherosclerosis: villain, accomplice, or innocent bystander?
Br Heart J. 1993 Jun;69(6):473-5. doi: 10.1136/hrt.69.6.473.
2
Development of vascular lesions in insulin-treated animals fed a normal diet.
Br Med J. 1970 Sep 19;3(5724):685-7. doi: 10.1136/bmj.3.5724.685.
3
Insulin and atherosclerosis.
N Engl J Med. 1979 Mar 22;300(12):679-80.
4
Role of insulin resistance and hyperinsulinemia in development of hypertension and atherosclerosis.
J Lab Clin Med. 1994 May;123(5):647-52.
5
[Insulin and atherogenesis].
Journ Annu Diabetol Hotel Dieu. 1990:171-9.
6
[Chronic insulin overdosage, hyperinsulinemia, atherosclerosis].
Klin Med (Mosk). 1996;74(8):40-3.
7
[Insulin resistance and atherosclerosis].
Acta Med Port. 2000 Jul-Aug;13(4):203-10.
8
[Is macroangiopathy a complication of diabetes mellitus? I.Hyper- insulinemia].
Przegl Lek. 1990;47(7):551-6.
9
[The role of hyperinsulinemia in the immunopathogenesis of atherosclerosis in diabetics].
Patol Fiziol Eksp Ter. 1991 Jul-Aug(4):41-3.
10
[Fibrinolytic system and hyperinsulinism].
Journ Annu Diabetol Hotel Dieu. 1990:181-91.
引用本文的文献
1
Acronym aggravation.
Br Heart J. 1994 Jan;71(1):107-9. doi: 10.1136/hrt.71.1.107.
2
Insulin in ischaemic heart disease: are associations explained by triglyceride concentrations? The Caerphilly prospective study.
Br Heart J. 1994 Mar;71(3):293-6. doi: 10.1136/hrt.71.3.293.
3
Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men.
BMJ. 1995 Mar 4;310(6979):560-4. doi: 10.1136/bmj.310.6979.560.
本文引用的文献
1
An epidemiological test of the hyperinsulinemia-hypertension hypothesis.
J Clin Endocrinol Metab. 1993 Mar;76(3):544-8. doi: 10.1210/jcem.76.3.8445009.
2
Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population.
Diabetologia. 1980 Sep;19(3):205-10. doi: 10.1007/BF00275270.
3
Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Busselton, Western Australia--13-year study.
J Chronic Dis. 1983;36(5):371-7. doi: 10.1016/0021-9681(83)90169-8.
4
Insulin and atheroma.
Lancet. 1969 May 31;1(7605):1078-80. doi: 10.1016/s0140-6736(69)91711-5.
5
Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.
J Clin Invest. 1985 Mar;75(3):809-17. doi: 10.1172/JCI111776.
6
Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin.
J Am Coll Cardiol. 1986 Dec;8(6):1245-55. doi: 10.1016/s0735-1097(86)80293-5.
7
Insulin resistance in essential hypertension.
N Engl J Med. 1987 Aug 6;317(6):350-7. doi: 10.1056/NEJM198708063170605.
8
Relationships between plasma lipoprotein concentrations and insulin action in an obese hyperinsulinemic population.
Diabetes. 1987 Aug;36(8):897-904. doi: 10.2337/diab.36.8.897.
9
Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics.
Metabolism. 1988 Apr;37(4):338-45. doi: 10.1016/0026-0495(88)90133-3.
10
Banting lecture 1988. Role of insulin resistance in human disease.
Diabetes. 1988 Dec;37(12):1595-607. doi: 10.2337/diab.37.12.1595.
Zotero 插件